Abstract

ObjectivesTo obtain a broad molecular epidemiological characterization of plasmid-mediated AmpC β-lactamase CMY-2 in Escherichia coli isolates from food animals in China.MethodsA total of 1083 E. coli isolates from feces, viscera, blood, drinking water, and sub-surface soil were examined for the presence of CMY-2 β-lactamases. CMY-2-producing isolates were characterized as follows: the bla CMY-2 genotype was determined using PCR and sequencing, characterization of the bla CMY-2 genetic environment, plasmid sizing using S1 nuclease pulsed-field gel electrophoresis (PFGE), PCR-based replicon typing, phylogenetic grouping, XbaI-PFGE, and multi-locus sequence typing (MLST).ResultsAll 31 CMY-2 producers were only detected in feces, and presented with multidrug resistant phenotypes. All CMY-2 strains also co-harbored genes conferring resistance to other antimicrobials, including extended spectrum β-lactamases genes (bla CTX-M-14 or bla CTX-M-55), plasmid-mediated quinolone resistance determinants (qnr, oqxA, and aac-(6′)-Ib-cr), floR and rmtB. The co-transferring of bla CMY-2 with qnrS1 and floR (alone and together) was mainly driven by the Inc A/C type plasmid, with sizes of 160 or 200 kb. Gene cassette arrays inserted in the class 1 or class 2 integron were amplified among 12 CMY-2 producers. CMY-2 producers belonged to avirulent groups B1 (n = 12) and A (n = 11), and virulent group D (n = 8). There was a good correlation between phylogenetic groups and sequence types (ST). Twenty-four STs were identified, of which the ST complexes (STC) 101/B1 (n = 6), STC10/A (n = 5), and STC155/B1 (n = 3) were dominant.ConclusionsCMY-2 is the dominant AmpC β-lactamase in food animals and is associated with a transferable replicon IncA/C plasmid in the STC101, STC10, and STC155 strains.

Highlights

  • The prevalence of plasmid-encoded AmpC blactamases, which confer resistance to extended-spectrum cephalosporins in Gram-negative bacilli, has increased in both humans and livestock isolates worldwide, and is a global problem [1]

  • Antimicrobial susceptibility A total of 233 (21.5%) out of 1083 E. coli isolates were resistant to cefoxitin with MIC values ranging from 8 mg/L to .512 mg/ L

  • Twenty-three blaCMY-2-bearing isolates were resistant to ceftiofur, a newly approved b-lactam for veterinary use in China

Read more

Summary

Introduction

The prevalence of plasmid-encoded AmpC (pAmpC) blactamases, which confer resistance to extended-spectrum cephalosporins in Gram-negative bacilli, has increased in both humans and livestock isolates worldwide, and is a global problem [1]. CMY-2 is the most common pAmpC in E. coli from different geographical areas including Asia, North America, and Europe [2,3,4,5], and has been reported in Salmonella and Escherichia coli isolates from a variety of food animals and products on all continents except Australia [6]. The resistance to multiple drugs, including third-generation cephalosporins, and the carriage of both pAmpC and extended spectrum b-lactamase (ESBL) genes in E. coli isolates from food animals has increased rapidly [14,15,16,17]. The aim of this study was to assess the molecular epidemiology and characteristics of CMY-2-bearing plasmidproducing E. coli in food animals including pigs, chickens, ducks, and geese

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call